Clarithromycin Related Published Studies
Well-designed clinical trials related to Clarithromycin
Compliance with and short-term adverse events from clarithromycin versus placebo in patients with stable coronary heart disease: the CLARICOR trial. [2009.08]
Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children. [2009.08]
Modeling the autoinhibition of clarithromycin metabolism during repeated oral administration. [2009.07]
Short-term clarithromycin administration impairs clearance and enhances pharmacodynamic effects of trazodone but not of zolpidem. [2009.06]
A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country. [2009.04]
Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure. [2009.04]
A PK/PD approach on the effects of clarithromycin against oral and nasal microbiota of healthy volunteers. [2009.02]
Generic versus non-generic formulation of extended-release clarithromycin in patients with community-acquired respiratory tract infections: a prospective, randomized, comparative, investigator-blind, multicentre study. [2009]
Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea. [2008.12]
Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities. [2008.12]
Influence of azithromycin and clarithromycin on macrolide susceptibility of viridans streptococci from the oral cavity of healthy volunteers. [2008.11]
Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. [2008.10]
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. [2008.07]
Clinical trial: randomized study of clarithromycin versus placebo in active Crohn's disease. [2008.06]
Prevalence of A2143G mutation of H. pylori-23S rRNA in Chinese subjects with and without clarithromycin use history. [2008.05.28]
Clarithromycin for 2 Weeks for Stable Coronary Heart Disease: 6-Year Follow-Up of the CLARICOR Randomized Trial and Updated Meta-Analysis of Antibiotics for Coronary Heart Disease. [2008.05.02]
Darunavir/ritonavir pharmacokinetics following coadministration with clarithromycin in healthy volunteers. [2008.01]
Clarithromycin for 2 Weeks for Stable Coronary Heart Disease: 6-Year Follow-Up of the CLARICOR Randomized Trial and Updated Meta-Analysis of Antibiotics for Coronary Heart Disease. [2008]
An open-label, randomized comparison of levofloxacin and amoxicillin/clavulanate plus clarithromycin for the treatment of hospitalized patients with community-acquired pneumonia. [2007.07]
Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. [2007.06]
Effects of clarithromycin and grapefruit juice on the pharmacokinetics of glibenclamide. [2007.06]
Effects of clarithromycin in patients with active rheumatoid arthritis. [2007.03]
Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. [2007.02.10]
Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study. [2007.02]
Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: a double-blind, randomized, placebo-controlled trial. [2006.10]
Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection. [2006.10]
Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease. [2006.09]
Effects of clarithromycin and verapamil on rabeprazole pharmacokinetics between CYP2C19 genotypes. [2006.08]
Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin. [2006.07.15]
Effect of oral clarithromycin on gall-bladder motility in normal subjects and those with gall-stones. [2006.07.01]
Comparing gatifloxacin and clarithromycin in pneumonia symptom resolution and process of care. [2006.04]
Studies on drug interactions between esomeprazole, amoxicillin and clarithromycin in healthy subjects. [2006.03]
Assessing the Clinical Significance of Botanical Supplementation on Human Cytochrome P450 3A Activity: Comparison of a Milk Thistle and Black Cohosh Product to Rifampin and Clarithromycin. [2006.02]
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. [2006.01.17]
Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial. [2006.01.07]
Effect of clarithromycin on the pharmacokinetics of cabergoline in healthy controls and in patients with Parkinson's disease. [2006.01]
Efficacy and safety of Helicobacter pylori eradication therapy with omeprazole, amoxicillin and high- and low-dose clarithromycin in Japanese patients: a randomised, double-blind, multicentre study. [2006]
[Efficacy and safety of extended-release clarithromycin (5-day short-course) vs telithromycin, in acute bacterial exacerbation of chronic bronchitis] [2005.10]
Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults. [2005.10]
Five-day telithromycin once daily is as effective as 10-day clarithromycin twice daily for the treatment of acute exacerbations of chronic bronchitis and is associated with reduced health-care resource utilization. [2005.10]
Pharmacokinetics of clarithromycin extended-release (ER) tablets in patients with AIDS. [2005.09]
Comparative bioavailability of clarithromycin formulations in healthy brazilian volunteers. [2005.08]
One-week dual therapy with ranitidine bismuth citrate and clarithromycin for the treatment of Helicobacter pylori infection in Brazilian patients with peptic ulcer. [2005.06.21]
Effect of clarithromycin on the enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes. [2005.06]
Efficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication of Helicobacter pylori in Chinese peptic ulcer patients. [2005.04.28]
Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin. [2005.03.21]
Effect of ketoconazole on the pharmacokinetics and safety of telithromycin and clarithromycin in older subjects with renal impairment. [2005.03]
Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes. [2005.03]
Effect of clarithromycin treatment on Chlamydia pneumoniae in vascular tissue of patients with coronary artery disease: a randomized, double-blind, placebo-controlled trial. [2005.03]
Treatment with clarithromycin prior to coronary artery bypass graft surgery does not prevent subsequent cardiac events. [2005.02.01]
Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis. [2005.02]
The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD. [2005.02]
Once daily clarithromycin extended-release vs twice-daily amoxicillin/clavulanate in patients with acute bacterial sinusitis: a randomized, investigator-blinded study. [2005.01]
Once-daily azithromycin for 3 days compared with clarithromycin for 10 days for acute exacerbation of chronic bronchitis: a multicenter, double-blind, randomized study. [2005]
Well-designed clinical trials possibly related to Clarithromycin
Oxidative stress in Helicobacter pylori infection: does supplementation with vitamins C and E increase the eradication rate? [2009.08]
Triple or quadruple tetracycline-based therapies versus standard triple treatment for Helicobacter pylori treatment. [2009.07]
Pharmacokinetic- pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori. [2009.05]
Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial. [2009.05]
The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection. [2009.04]
Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children. [2009.04]
Efficacy of a new therapeutic regimen versus two routinely prescribed treatments for eradication of Helicobacter pylori: a randomized, double-blind study of doxycycline, co-amoxiclav, and omeprazole in Iranian patients. [2009.03]
Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial. [2009.02]
A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children. [2009.01]
Helicobacter pylori eradication in long-term proton pump inhibitor users is highly cost-effective: economic analysis of the HELPUP trial. [2008.12.01]
Moxifloxacine plus amoxicillin and ranitidine bismuth citrate or esomeprazole triple therapies for Helicobacter pylori infection. [2008.12]
Gatifloxacin-based triple therapy as a third-line regimen for Helicobacter pylori eradication. [2008.12]
Causal relationship of Helicobacter pylori with iron-deficiency anemia or failure of iron supplementation in children. [2008.11]
[Effect of Helicobacter pylori eradication on patients with functional dyspepsia] [2008.09]
Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment. [2008.06.17]
Effect of a community screening for Helicobacter pylori: a 5-Yr follow-up study. [2008.05]
13C-urea breath test values and Helicobacter pylori eradication. [2008.02]
Preoperative versus postoperative Helicobacter pylori eradication therapy in gastric cancer patients: a randomized trial. [2008.01]
Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy. [2008.01]
Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo. [2008.01]
Smoking and drinking habits are important predictors of Helicobacter pylori eradication. [2008]
Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use. [2007.11.01]
Role of sequential therapy in Helicobacter pylori eradication therapy. [2007.10]
Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial. [2007.10]
Comparative Study of Levofloxacin in the Treatment of Children With Community-Acquired Pneumonia. [2007.10]
Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test. [2007.10]
The effect of probiotics on Helicobacter pylori eradication. [2007.10]
High-dose versus low-dose esomeprazole-based triple therapy for Helicobacter pylori infection. [2007.09]
Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study. [2007.09]
Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial. [2007.08]
Levofloxacin-Containing Triple Therapy to Eradicate the Persistent H. pylori after a Failed Conventional Triple Therapy. [2007.08]
Efficacy and Safety of Saccharomyces boulardii in the 14-day Triple Anti-Helicobacter pylori Therapy: A Prospective Randomized Placebo-Controlled Double-Blind Study. [2007.08]
Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy. [2007.08]
Improvement in symptoms after H(2)-receptor antagonist-based therapy for eradication of H pylori infection. [2007.07.28]
Optimal length of triple therapy for H pylori eradication in a population with high prevalence of infection in Chile. [2007.06.07]
High eradication rate of H. pylori with moxifloxacin-based treatment: a randomized controlled trial. [2007.06]
[Different courses of esomeprazole-based triple therapy for Helicobactor pylori infection in children] [2007.06]
Effect of cranberry juice on eradication of Helicobacter pylori in patients treated with antibiotics and a proton pump inhibitor. [2007.06]
One week of esomeprazole triple therapy vs 1 week of omeprazole triple therapy plus 3 weeks of omeprazole for duodenal ulcer healding in Helicobacter pylori-positive patients. [2007.06]
Rabeprazole-based eradication therapy for Helicobacter pylori: a large-scale study in Japan. [2007.05.01]
Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics. [2007.05]
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. [2007.04.17]
Surgical excision versus antibiotic treatment for nontuberculous mycobacterial cervicofacial lymphadenitis in children: a multicenter, randomized, controlled trial. [2007.04.15]
Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori. [2007.04]
Efficacy of low-dose proton pump inhibitor (PPI) in the eradication of Helicobacter pylori following combination PPI/AC therapy in Japan. [2007.03]
[Helicobacter pylori erradication and its relation to antibiotic resistance and CYP2C19 status] [2007.02]
High eradication rate of H. pylori with moxifloxacin-based treatment: a randomized controlled trial. [2007]
|
